| ProCon.org |
U.S. Court of Appeals for the D.C. Circuit Will Hear Oral Arguments Tuesday
DPA Statement: Feds’ Claim of “No Medical Use” Ignores Science
For the first time in 20 years, the U.S. Court of Appeals for the District of Columbia Circuit will hear oral arguments on Tuesday, October 16, in a case challenging the Drug Enforcement Administration’s decision to designate marijuana as a Schedule I substance. Schedule I is the most restrictive category for controlled substances, including those drugs defined as having a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision.